Search Results
Apr 22, 2026, 09:00 ET Nature Reviews Drug Discovery | Target Identification and Assessment in the Era of AI
and various deep learning (DL)-based mode-specific algorithms that identify aging and disease biomarkers and targets from patients' blood chemistry, DNA methylation, gut microbiome, or transcriptome data.In contrast, unsupervised and semi-supervised learning methods identify hidden biological
More news about: Insilico Medicine
Apr 22, 2026, 07:00 ET Actinium Highlights Transcriptional Reprogramming as a Key Mechanism Underpinning Mutation-Agnostic Activity of Actimab-A in AML at the 2026 American Association of Cancer Research Annual Meeting
settings.Actimab-A is Actinium's lead clinical radiotherapy delivering Actinium-225, a potent alpha-emitter radioisotope payload that produces lethal double-strand DNA breaks to kill CD33-expressing AML cells. CD33 is expressed ubiquitously in AML and other myeloid malignancies. Actimab-A has been evaluated in more
More news about: Actinium Pharmaceuticals, Inc.
Apr 22, 2026, 07:00 ET Actinium Pharmaceuticals, Inc. Announces Compelling Pan-Tumor Data for ATNM-400 Demonstrating Broad Efficacy Across Prostate, Lung, and Breast Cancer Models at the 2026 American Association of Cancer Research Annual Meeting
potent alpha emitter that, compared to beta emitters such as Lu-177, delivers high-energy radiation capable of inducing irreversible double-stranded DNA breaks, with a shorter path length that may limit off-target effects and enhance therapeutic precision. Together, this target-and-isotope combination
More news about: Actinium Pharmaceuticals, Inc.
Apr 22, 2026, 04:30 ET EZVIZ aderisce al Global Compact delle Nazioni Unite, aprendo un nuovo capitolo del suo impegno costante verso la sostenibilità a lungo termine e ampliando ulteriormente il proprio contributo alle principali questioni ambientali
oltre che per fissare limiti più rigorosi al fine di evitare di sacrificare l'ambiente a vantaggio del profitto commerciale».Con il verde nel DNA del marchio, l'azienda ha anche sviluppato una tecnologia ecologica a basse emissioni di carbonio. La tecnologia AOV a basso consumo energetico e la
More news about: EZVIZ
Apr 21, 2026, 20:53 ET Kelun-Biotech Announces Three Clinical Study Results Selected for Oral Presentations at 2026 ASCO Annual Meeting
antibodies, which is then endocytosed by tumor cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment.
More news about: Kelun-Biotech
Apr 21, 2026, 16:05 ET Jazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca® (lurbinectedin)
(lurbinectedin)Zepzelca is an alkylating drug that binds guanine residues within DNA. This triggers a cascade of events that can affect the activity of DNA binding proteins, including some transcription factors, and DNA repair pathways, resulting in disruption of the cell cycle and potentially cell death.2In October
More news about: Jazz Pharmaceuticals plc
Apr 21, 2026, 13:25 ET Mphasis acquires Theory and Practice Business Intelligence Inc., strengthening its 'Decisioning Intelligence' capabilities
team of experts in AI, data science, and behavioral economics.About Mphasis At Mphasis, engineering has been in our DNA since inception.Mphasis is an AI-led, platform-driven company with human-in-the-loop intelligence, helping global enterprises modernize, infuse
More news about: Mphasis
Apr 21, 2026, 13:19 ET CancerCheck Early-Detection Blood Test Uses Gold-Standard Methodology
detection (MCED) screening tests do not isolate CTCs for review by a human, board-certified pathologist; rather, they use biomarkers, circulating-tumor DNA (ctDNA), proteins, or small molecule metabolites to detect if positive cancer signals exist, which can lead to inaccurate, pathologically unconfirmed
More news about: Cancer Check Labs
Apr 21, 2026, 11:32 ET The Lab Catches Up to the Clinic: How Functional Precision Oncology Goes Beyond Genomics
/PRNewswire/ -- For decades, oncologists have had a powerful but imperfect ally in the fight against cancer: genomic testing. The ability to sequence a tumor's DNA and identify targetable mutations transformed the field, offering the promise of personalized treatment. Yet many clinicians continue to face an unsettling
More news about: First Ascent Biomedical
Apr 21, 2026, 08:23 ET Novakid spúšťa NovaPals, konverzačnú aplikáciu s AI určenú na samostatné precvičovanie angličtiny
prevzatie týchto odborných znalostí a ich prepracovanie do zážitku s AI. Toto nie je AI navrstvená na tradičný obsah, je to produkt navrhnutý od začiatku dňa s ohľadom na to, čo konverzačná AI robí najlepšie: ide o personalizovanú a adaptívnu prax vo veľkej mierke."NovaPals stavia na poznatkoch
More news about: NovaKid
Apr 21, 2026, 08:01 ET Seed Health and The Two Frontiers Project Launch Initiative to Explore Microbial Solutions to "Forever Chemicals"
associated with long-term chemical exposure. Findings will contribute to 2FP's Living Database: an open-access archive that provides global researchers with DNA sequencing data and cultured samples from these unique environments. This distributed, community-powered model gives researchers access to environments
More news about: Seed Health
Apr 21, 2026, 08:00 ET FDA Breakthrough for First Viral-Integration MRD Liquid Biopsy in HCC -- New ctDNA Biomarker Class
calling.Published and presented clinical data (Hepatology; Cellular and Molecular Gastroenterology and Hepatology; AASLD 2023) include:vh-DNA detected in 98% of pre-surgical plasma; detection limit ~1.5 cm158-day mean lead time over CT for recurrence detectionNPV 92%, PPV
More news about: TCM Biotech
Apr 21, 2026, 07:00 ET Greenvit Debuts ARONVIT® for Gut Health and Microbiota at Vitafoods Europe
Absorbance Capacity) scale, a measure of the ability to reduce the radical oxygen molecules that lead to lipid peroxidation and damage of the cellular DNA. ARONVIT® is sourced from the special Nero-Eggert variety of aronia berries, a variety recognized for its high yield of polyphenols.Polyphenols vs.
More news about: Greenvit
Apr 21, 2026, 06:30 ET Flagship Pioneering Launches Serif Biomedicines to Establish Modified DNA as a New Biotechnology
category-originating Flagship companies to establish Modified DNA as a practical and broadly applicable therapeutic platform."Serif is building the complete technology stack to unlock non-viral DNA therapeutics in a capital-efficient manner, combining Modified DNA that minimizes innate immunogenicity, co-delivered
More news about: Flagship Pioneering
Apr 20, 2026, 13:11 ET The Inner Circle acknowledges Clinton Jones as a Pinnacle Professional Member Inner Circle of Excellence
Jones, a nationally recognized leader in virology, has served at Oklahoma State University (OSU) since 2015, where he leads groundbreaking research on DNA viruses and viral pathogenesis. His laboratory's work has advanced the global understanding of herpesvirus latency and reactivation, with particular
More news about: The Inner Circle
Apr 20, 2026, 11:12 ET Cure Companies Welcomes Bombas Co-Founder Dave Heath as Strategic Investor and Board Member
historically been underserved at this level of quality. I've seen what happens when you build something people truly belong to, and Cure Companies has that DNA. The opportunity is real, and the timing is right."— Dave Heath, Co-Founder, Bombas | Board Member, Cure CompaniesIn addition
More news about: Cure Companies
Apr 20, 2026, 09:30 ET Atlas Data Storage Selected to Present at TSMC Technology Symposium
StorageAtlas Data Storage is pioneering the next era of digital preservation by commercializing synthetic DNA-based data storage. Optimized by nature for durability, density, and duplication, DNA is the ideal media to keep data safe -- forever. Atlas technology provides a low-maintenance and environmentally
More news about: Atlas Data Storage
Apr 20, 2026, 08:30 ET Pinnacle Food Group Limited Announces Entry Into a Non-Binding MOU to Explore Establishing an Open Yeast Platform Hub in Hong Kong
parts. The first is the Open Yeast Collection, an open-source collection of DNA parts for assembling genetic constructs in yeast, originally established by Dr. Scott Pownall in 2021. The current library contains hundreds of valuable DNA assembly parts to support synthetic biology research and biotechnology
More news about: Pinnacle Food Group Limited
Apr 20, 2026, 08:15 ET MDA SPACE CONTRACTED BY AIRBUS FOR REPEAT ORDER OF ANTENNAS FOR ONEWEB CONSTELLATION EXTENSION
vision into an achievable mission—bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Apr 20, 2026, 08:00 ET Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update
Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Apr 20, 2026, 02:30 ET New Combination Therapy for Advanced Small Cell, Lung Cancer Approved in Australia and Singapore
timely and equitable access to this new treatment."ZEPZELCA belongs to a class of medicines known as alkylating agents, which work by damaging the DNA of cancer cells, helping to slow or stop their growth.[12] The regulatory approvals for ES-SCLC in Australia and Singapore were based on results
More news about: Specialised Therapeutics
Apr 18, 2026, 19:44 ET BREAKTHROUGH PRIZE ANNOUNCES 2026 LAUREATES
that inactivating it restored fetal hemoglobin production in mice and eliminated sickle cell disease symptoms. His laboratory identified a specific DNA enhancer region that controls BCL11A expression itself, but crucially only in red blood cells, providing a precise and safe target for therapeutic intervention
More news about: Breakthrough Prize
Apr 18, 2026, 19:35 ET Breakthrough Prize Foundation Announces Winner of the 11th Annual Breakthrough Junior Challenge
Through world-renowned science and education divisions, CSHL nurtures a culture of curiosity, discovery, and innovation to make lives better. CSHL's DNA Learning Center (DNALC) is the largest provider of hands-on instruction in genetics and biotechnology, reaching nearly 40,000 middle and high school
More news about: Breakthrough Prize
Apr 18, 2026, 19:01 ET Penn Medicine, Children's Hospital of Philadelphia team awarded Breakthrough Prize for developing gene therapy for inherited blindness
blindness, usually by their 20s, but sometimes in early childhood.The pair developed a therapy that used a virus as a transport, carrying a piece of DNA into cells that would then correct the faulty, blindness-causing proteins formed by the bad gene. The idea: Once the proteins were set right, some sight
More news about: Children's Hospital of Philadelphia
Apr 17, 2026, 09:06 ET Once Upon a Farm Achieves WIC Approval in California, Reaching 20-State Milestone
raising the standard for childhood nutrition and proving that fresh, nutritious, baby food isn't just possible but accessible is in Once Upon a Farm's DNA.Making Childhood Nutrition Healthier, Happier and More EquitableOnce Upon a Farm's participation in the WIC program reflects the
More news about: Once Upon a Farm, PBC